AMRYT PHARMA PLC - SPNR ADR (AMYT)
US03217L1061 - ADR
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -87.53M | -104.53M | -65.53M | -30.49M | -30.63M | |||
| Depreciation Amortization | 46.39M | 44.47M | 12.65M | 367.00K | 303.50K | |||
| Income Taxes - Deferred | -13.76M | -535.00K | -1.67M | 0.00 | N/A | |||
| Change In Working Capital | -112.92M | -4.39M | -11.88M | 1.44M | 1.78M | |||
| Interest Paid | 12.19M | 10.78M | 6.25M | 283.00K | N/A | |||
| Other non cash items | 81.71M | 91.88M | 28.93M | 13.23M | 14.64M | |||
| OPERATING CASH FLOW | -86.12M | 26.89M | -37.50M | -15.45M | -13.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.94M | -2.47M | -652.00K | -235.00K | -386.69K | |||
| Other Investing Activity | 107.95M | 87.00K | 25.08M | 6.00K | 16.41K | |||
| INVESTING CASH FLOW | 105.00M | -2.38M | 24.43M | -229.00K | -370.29K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.06M | -1.12M | 9.19M | 5.91M | 11.66M | |||
| Stock Issued/Repurchased | 37.81M | 37.93M | 63.01M | 0.00 | 16.87M | |||
| Other Financing Activity | -12.19M | -10.78M | -6.25M | -2.65M | 0.00 | |||
| FINANCING CASH FLOW | 24.56M | 26.03M | 65.94M | 3.27M | 28.53M | |||
| Exchange Rate Effect | 4.35M | 1.03M | 3.13M | -767.00K | 86.71K | |||
| CHANGE IN CASH | 47.79M | 51.57M | 56.00M | -13.18M | 14.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -86.12M | 26.89M | -37.50M | -15.45M | -13.90M | |||
| Capital Expenditure | -2.94M | -2.47M | -652.00K | -235.00K | -386.69K | |||
| FREE CASH FLOW | -89.06M | 24.42M | -38.15M | -15.69M | -14.29M | |||
All data in USD